Burden of cervical, anal, and oral HPV in an inner-city pre-vaccine adolescent population (Q36629357)

15 August 2017

0 references

Burden of cervical, anal, and oral HPV in an inner-city pre-vaccine adolescent population (English)

1 reference

15 August 2017

0 references

1 reference

6

Robert D Burk

1 reference

15 August 2017

5

Howard D Strickler

1 reference

15 August 2017

Nicolas F Schlecht

1

1 reference

15 August 2017

Mary Rojas

2

1 reference

15 August 2017

Elizabeth Lorde-Rollins

3

1 reference

15 August 2017

Anne Nucci-Sack

4

1 reference

15 August 2017

Angela Diaz

7

1 reference

15 August 2017

1 February 2013

1 reference

15 August 2017

Journal of Urban Health

1 reference

15 August 2017

90

1 reference

15 August 2017

1

1 reference

15 August 2017

141-146

1 reference

Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

A review of human carcinogens--Part B: biological agents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

30 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11524-012-9756-9

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11524-012-9756-9

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11524-012-9756-9

Prevalence of oral HPV infection in the United States, 2009-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11524-012-9756-9

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11524-012-9756-9

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3579307

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22932952

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparisons of HPV DNA detection by MY09/11 PCR methods

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22932952

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11524-012-9756-9

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

22932952

1 reference